Skip to main content

Clinical Pharmacology and Therapeutic Use of the Narcotic Antagonist: Naltrexone

  • Chapter
Social and Medical Aspects of Drug Abuse
  • 82 Accesses

Abstract

Due to the chemical complexity of the human organism it is difficult to imagine that any one chemical agent would produce a single pharmacological effect. The “magic bullet” theory, envisioned by Paul Erlich around the turn of the century, postulated that after drug administration the drug is absorbed, transported by the blood to its site of action, performs the desired pharmacological action without effecting other cells or organs and then excreted. It was soon discovered that such selective chemicals were nonexistent. After searching for decades, scientists had to be satisfied by finding chemicals with the minimal number and least severe side effects. Interestingly, naltrexone seems to be close to the description of the “magic bullet.”

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 16.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Blumberg H, Pachter IJ and Matossian Z: US Patent 3, 332, 950 (July 25, 1976)

    Google Scholar 

  • Cone EJ: Human metabolite of naltrexone (N-cyclopropylmethylnoroxymorphone) with a novel C-6 isomorphine configuration. Tetrahedron Lett 23:2607–2610, 1973

    Article  Google Scholar 

  • Hiller J and Simon E: New York University Medical School, Personal Communication, 1979

    Google Scholar 

  • Martin WR, Gorodetzky CW and McClane TK: An experimental study in the treatment of narcotic addicts with cyclazocine. Clin Pharmacol Ther 7:455–465, 1966

    PubMed  CAS  Google Scholar 

  • Verebey K and Mulé SJ: Naltrexone pharmacology, pharmacokinetics and metabolism: Current status. Am J Drug Alcohol Abuse 2:357–363, 1975

    Article  PubMed  CAS  Google Scholar 

  • Verebey K and Mulé SJ: Naltrexone and 6β-naltrexol plasma levels in schizophrenic patients after large doses of naltrexone. Res Commun Psychol, Psychiatry & Behavior 4:311–317, 1979

    CAS  Google Scholar 

  • Verebey K, Chedekel MA, Mulé SJ and Rosenthal D: Isolation and identification of a new metabolite of naltrexone in human blood and urine. Res Commun Chem Pathol Pharmacol 12:67–84, 1975

    Google Scholar 

  • Verebey K, DePace A, Jukofsky D, Volavka JV and Mulé SJ: Quantitative determination of 2-hydroxy-3-methoxy-6β-naltrexol (HMN), naltrexone, and 6β-naltrexol in human plasma, red blood cells, sauva and urine by gas liquid chromatography. J Analytical Toxicol 4:33–37, 1980

    CAS  Google Scholar 

  • Verebey K, Volavka J, Mulé SJ and Resnick RB: Naltrexone: Disposition, metabolism and effects after acute and chronic dosing. Clin Pharmacol Ther 20:315–328, 1976

    PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1984 Spectrum Publications, Inc.

About this chapter

Cite this chapter

Verebey, K. (1984). Clinical Pharmacology and Therapeutic Use of the Narcotic Antagonist: Naltrexone. In: Serban, G. (eds) Social and Medical Aspects of Drug Abuse. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-6320-0_16

Download citation

  • DOI: https://doi.org/10.1007/978-94-011-6320-0_16

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-011-6322-4

  • Online ISBN: 978-94-011-6320-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics